BackTabula Rasa HealthCare Overview

Tabula Rasa HealthCare EBIT

Latest ebit for TRHC: $-43M, below the Consumer Staples sector average of $1.2T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$5.12M
↑ 49.29% YoY

As of Jun 30, 2023

Annual EBIT (TTM)

-$42.87M
↑ 25.76% YoY

Trailing 12 months ending Jun 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Tabula Rasa HealthCare (TRHC) FAQ

The latest EBIT for TRHC is $-43M as of June 2023. That compares with $-58M in the prior-year period — up 25.8% year over year. That is below the Consumer Staples sector average of $1.2T. Investors often review this figure alongside Tabula Rasa HealthCare's historical trend and sector peers before judging valuation or financial health.

Over the past year, TRHC's EBIT moved from $-58M to $-43M — a 25.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tabula Rasa HealthCare's operating scale or balance-sheet position.

Against Consumer Staples companies, TRHC currently prints $-43M for EBIT, while the sector average sits near $1.2T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Tabula Rasa HealthCare's growth, margins, and balance sheet.

A EBIT figure of $-43M for TRHC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Staples average is about $1.2T. Explore the charts below for those layers of context.

After noting TRHC's EBIT ($-43M), review year-over-year change from $-58M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.